HealthQuill Women
British-Swedish AstraZeneca has acquired Amolyt Pharma for $1.05 billion to gain access to Lyon, France-based company’s rare disease, late-stage pipeline.
Drugs Health Pharma

AstraZeneca acquires France’s Amolyt Pharma for $1.05 billion

British-Swedish AstraZeneca has acquired Amolyt Pharma for $1.05 billion to gain access to Lyon, France-based company’s rare disease, late-stage pipeline.

Read More
About 16% of children or one in six children under two years of age in the Northern Gaza Strip, which has been cut off from aid for weeks, are “acutely malnourished,” according to a WHO report based on data collected in January.
Drugs Health Pharma

Hunger, diseases grip undernourished children, women in Gaza: WHO report

HQ Team February 20, 2024: About 16% of children or one in six children under two years of age in the Northern Gaza.

Read More
Switzerland’s healthcare company, Roche, signed a pact with US-based Alnylam to jointly develop and commercialize a therapy to treat hypertension in people with high cardiovascular risk.
Drugs Health Medical

Molecular coating on X chromosomes may explain higher autoimmune susceptibility in women

Bharti Jayshankar February 2, 2024: A new study has come up with an explanation for the heightened susceptibility of women to autoimmune diseases.

Read More
Physicians and scientists are on the lookout for a new non-invasive diagnostic process for a lesser-known condition called adenomyosis in women.
Drugs Health Pharma

Scientists’ eye easy diagnosis for adenomyosis condition in women

Physicians and scientists are on the lookout for a new non-invasive diagnostic process for a lesser-known condition called adenomyosis in women.

Read More
X